This protocol addresses outpatients with suspected or confirmed influenza who remain at home (not hospitalised) but are developing complications or experiencing progressive disease more than two days after symptom onset — a presentation that calls for a different management approach than uncomplicated early-onset illness.
Patients seen in an outpatient setting with suspected or confirmed influenza, where symptoms have been present for more than 48 hours and the clinical picture is worsening or complicated — for example, progression toward pneumonia or exacerbation of an underlying chronic medical condition. These patients are not yet hospitalised.
Guidelines recommend initiating oral antiviral therapy as soon as possible in this setting, even beyond the typical 48-hour window. The complete regimen — including agent selection, dose adjustments, and duration — is available in the full protocol.
Shortening the duration of fever and influenza illness symptoms; achieving resolution of fever and influenza symptoms.
For outpatients with complications or progressive disease >2 days after symptom onset and suspected or confirmed influenza (e.g., pneumonia, or exacerbation of underlying chronic medical conditions), initiation of antiviral treatment with oral oseltamivir is recommended as soon as possible.
Clinical trials and observational data show that early antiviral treatment can shorten the duration of fever and illness symptoms, and may reduce the risk of some complications from influenza (e.g., otitis media in young children, pneumonia, and respiratory failure).
DOI: 10.1093/cid/ciy866
View source ↗